These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital. Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782 [TBL] [Abstract][Full Text] [Related]
25. Anticipated and perceived pain from midtrimester amniocentesis. Karasahin E; Gungor S; Goktolga U; Keskin U; Gezginc K; Baser I Int J Gynaecol Obstet; 2008 Jun; 101(3):290-4. PubMed ID: 18279876 [TBL] [Abstract][Full Text] [Related]
26. Midtrimester genetic amniocentesis in eastern Ontario: a review from 1970 to 1985. Hunter AG; Thompson D; Speevak M J Med Genet; 1987 Jun; 24(6):335-43. PubMed ID: 3612705 [TBL] [Abstract][Full Text] [Related]
27. Reproductive behaviour and prenatal diagnosis following genetic termination of pregnancy in women of advanced maternal age. Brandenburg H; De Koning W; Jahoda MG; Stijnen T; De Ridder MA; Sachs ES; Wladimiroff JW Prenat Diagn; 1992 Dec; 12(12):1031-5. PubMed ID: 1287638 [TBL] [Abstract][Full Text] [Related]
28. The risk of second-trimester amniocentesis in twin gestations: a case-control study. Ghidini A; Lynch L; Hicks C; Alvarez M; Lockwood CJ Am J Obstet Gynecol; 1993 Oct; 169(4):1013-6. PubMed ID: 8238111 [TBL] [Abstract][Full Text] [Related]
29. Five hundred cases of amniocentesis without bloody tap. Katayama KP; Roesler MR Obstet Gynecol; 1986 Jul; 68(1):70-3. PubMed ID: 3523332 [TBL] [Abstract][Full Text] [Related]
30. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Picone O; Senat MV; Rosenblatt J; Audibert F; Tachdjian G; Frydman R Fetal Diagn Ther; 2008; 23(1):30-5. PubMed ID: 17934295 [TBL] [Abstract][Full Text] [Related]
31. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Lancet; 1998 Jan; 351(9098):242-7. PubMed ID: 9457093 [TBL] [Abstract][Full Text] [Related]
32. Reproductive outcome following amniocentesis for genetic indications. Porreco RP; Young PE; Resnik R; Cousins L; Jones OW; Richards T; Kernahan C; Matson M Am J Obstet Gynecol; 1982 Jul; 143(6):653-60. PubMed ID: 7091237 [No Abstract] [Full Text] [Related]
33. Congenital talipes and hip malformation in relation to amniocentesis: a case-control study. Wald NJ; Terzian E; Vickers PA; Weatherall JA Lancet; 1983 Jul; 2(8344):246-9. PubMed ID: 6135078 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks' gestation. Brumfield CG; Lin S; Conner W; Cosper P; Davis RO; Owen J Obstet Gynecol; 1996 Jul; 88(1):114-8. PubMed ID: 8684742 [TBL] [Abstract][Full Text] [Related]
35. Population-based study of long-term outcomes after amniocentesis. Baird PA; Yee IM; Sadovnick AD Lancet; 1994 Oct; 344(8930):1134-6. PubMed ID: 7934498 [TBL] [Abstract][Full Text] [Related]
36. Midtrimester amniocentesis. Indications, technique, risks and potential for prenatal diagnosis. Roberts NS; Dunn LK; Weiner S; Godmilow L; Miller R J Reprod Med; 1983 Mar; 28(3):167-88. PubMed ID: 6189994 [No Abstract] [Full Text] [Related]
37. The significance of meconium in midtrimester genetic amniocentesis. Allen R Am J Obstet Gynecol; 1985 Jun; 152(4):413-7. PubMed ID: 2409795 [TBL] [Abstract][Full Text] [Related]
38. Elevated maternal serum alpha-fetoprotein caused by midtrimester amniocentesis: a prognostic factor. Thomsen SG; Isager-Sally L; Lange AP; Saurbrey N; Grønvall S; Schiøler V Obstet Gynecol; 1983 Sep; 62(3):297-300. PubMed ID: 6192372 [TBL] [Abstract][Full Text] [Related]